These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 33039583)
1. Galangin treatment during dendritic cell differentiation confers tolerogenic properties in response to lipopolysaccharide stimulation. Song HY; Kim WS; Han JM; Seo HS; Lim ST; Byun EB J Nutr Biochem; 2021 Jan; 87():108524. PubMed ID: 33039583 [TBL] [Abstract][Full Text] [Related]
2. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity. Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902 [TBL] [Abstract][Full Text] [Related]
3. HMOC, a chrysin derivative, induces tolerogenic properties in lipopolysaccharide-stimulated dendritic cells. Song HY; Sik Kim W; Moo Han J; Yong Park W; Lim ST; Byun EB Int Immunopharmacol; 2021 Jun; 95():107523. PubMed ID: 33706053 [TBL] [Abstract][Full Text] [Related]
4. Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes. Besin G; Gaudreau S; Ménard M; Guindi C; Dupuis G; Amrani A Diabetes; 2008 Aug; 57(8):2107-17. PubMed ID: 18477807 [TBL] [Abstract][Full Text] [Related]
5. Generation of dendritic cells with regulatory properties. Ureta G; Osorio F; Morales J; Rosemblatt M; Bono MR; Fierro JA Transplant Proc; 2007 Apr; 39(3):633-7. PubMed ID: 17445563 [TBL] [Abstract][Full Text] [Related]
6. Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells. Yan F; Cai L; Hui Y; Chen S; Meng H; Huang Z Cell Biol Int; 2014 Jul; 38(7):835-48. PubMed ID: 24604878 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of herpesvirus entry mediator in 1,25-dihydroxyvitamin D3-treated mouse bone marrow-derived dendritic cells promotes the generation of CD4⁺CD25⁺Foxp3⁺ regulatory T cells. Huang Y; Zhao Y; Ran X; Wang C Mol Med Rep; 2014 Mar; 9(3):813-8. PubMed ID: 24366217 [TBL] [Abstract][Full Text] [Related]
8. Nrf2-mediated metabolic reprogramming of tolerogenic dendritic cells is protective against aplastic anemia. Wei HJ; Gupta A; Kao WM; Almudallal O; Letterio JJ; Pareek TK J Autoimmun; 2018 Nov; 94():33-44. PubMed ID: 30025621 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of clinical grade human tolerogenic dendritic cells. Naranjo-Gómez M; Raïch-Regué D; Oñate C; Grau-López L; Ramo-Tello C; Pujol-Borrell R; Martínez-Cáceres E; Borràs FE J Transl Med; 2011 Jun; 9():89. PubMed ID: 21658226 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Svajger U; Obermajer N; Jeras M Immunology; 2010 Apr; 129(4):525-35. PubMed ID: 20002210 [TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128 [TBL] [Abstract][Full Text] [Related]
12. APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells. Pellerin L; Chen P; Gregori S; Hernandez-Hoyos G; Bacchetta R; Roncarolo MG Front Immunol; 2018; 9():881. PubMed ID: 29887861 [TBL] [Abstract][Full Text] [Related]
13. Programmed death ligand 1 (PD-L1) plays a vital part in DC tolerogenicity induced by IFN-γ. Švajger U; Tešić N; Rožman P Int Immunopharmacol; 2021 Oct; 99():107978. PubMed ID: 34298399 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cells treated with a prostaglandin I Wong TH; Gau RJ; Chen YF; Shen HH; Lin CT; Chen SL; Suen JL Int Immunopharmacol; 2020 Feb; 79():106106. PubMed ID: 31874369 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury. Lu Z; Chang W; Meng S; Xu X; Xie J; Guo F; Yang Y; Qiu H; Liu L Stem Cell Res Ther; 2019 Dec; 10(1):372. PubMed ID: 31801626 [TBL] [Abstract][Full Text] [Related]
16. Induction of tolerance-inducing antigen-presenting cells in bone marrow cultures in vitro using monoclonal antibodies to CD200R. Gorczynski RM; Chen Z; Kai Y; Wong S; Lee L Transplantation; 2004 Apr; 77(8):1138-44. PubMed ID: 15114074 [TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-loaded liposomes induce human mucosal CD103 Nagy NA; Hafkamp FMJ; Sparrius R; Bas R; Lozano Vigario F; van Capel TMM; van Ree R; Geijtenbeek TBH; Slütter B; Tas SW; de Jong EC Eur J Immunol; 2024 May; 54(5):e2350839. PubMed ID: 38430190 [TBL] [Abstract][Full Text] [Related]
18. Protosappanin A protects against experimental autoimmune myocarditis, and induces metabolically reprogrammed tolerogenic DCs. Wu J; Liu M; Mang G; Yu S; Chen Q; Li T; Wang Y; Meng Y; Tang X; Zheng Y; Sun Y; Zhang M; Yu B Pharmacol Res; 2019 Aug; 146():104269. PubMed ID: 31078745 [TBL] [Abstract][Full Text] [Related]
19. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses. Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934 [TBL] [Abstract][Full Text] [Related]
20. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype. Gleisner MA; Rosemblatt M; Fierro JA; Bono MR Transplant Proc; 2011; 43(6):2325-33. PubMed ID: 21839264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]